EP0692969A4 - Methode zur behandlung von krankheiten durch deletion von t zellen - Google Patents

Methode zur behandlung von krankheiten durch deletion von t zellen

Info

Publication number: EP0692969A4
Authority: EP; European Patent Office
Prior art keywords: deletion; diseases; cells; treatment
Prior art date: 1993-04-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP94912969A

Other languages

English (en)

French (fr)

Other versions

EP0692969A1 (de

Inventor

Philippa Marrack

John Kappler

James E Mccormack

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

National Jewish Health

Original Assignee

National Jewish Center for Immunology and Respiratory Medicine

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-08

Filing date

1994-04-08

Publication date

1997-08-20

1994-04-08 Application filed by National Jewish Center for Immunology and Respiratory Medicine filed Critical National Jewish Center for Immunology and Respiratory Medicine

1996-01-24 Publication of EP0692969A1 publication Critical patent/EP0692969A1/de

1997-08-20 Publication of EP0692969A4 publication Critical patent/EP0692969A4/de

Status Withdrawn legal-status Critical Current

Links

210000001744 T-lymphocyte Anatomy 0.000 title 1
238000012217 deletion Methods 0.000 title 1
230000037430 deletion Effects 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Mycology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EP94912969A 1993-04-08 1994-04-08 Methode zur behandlung von krankheiten durch deletion von t zellen Withdrawn EP0692969A4 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US45494		1979-06-04
US4549493A	1993-04-08	1993-04-08
PCT/US1994/003861 WO1994023734A1 (en)	1993-04-08	1994-04-08	Method of treatment of diseases by deletion of t cells

Publications (2)

Publication Number	Publication Date
EP0692969A1 EP0692969A1 (de)	1996-01-24
EP0692969A4 true EP0692969A4 (de)	1997-08-20

Family

ID=21938212

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP94912969A Withdrawn EP0692969A4 (de)	1993-04-08	1994-04-08	Methode zur behandlung von krankheiten durch deletion von t zellen

Country Status (5)

Country	Link
EP (1)	EP0692969A4 (de)
JP (1)	JPH08508752A (de)
AU (1)	AU6530794A (de)
CA (1)	CA2159891A1 (de)
WO (1)	WO1994023734A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7572631B2 (en)	2000-02-24	2009-08-11	Invitrogen Corporation	Activation and expansion of T cells
US7541184B2 (en)	2000-02-24	2009-06-02	Invitrogen Corporation	Activation and expansion of cells
US20050084967A1 (en)	2002-06-28	2005-04-21	Xcyte Therapies, Inc.	Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1991012818A1 (en) *	1990-02-23	1991-09-05	Immulogic Pharmaceutical Corporation	Superantigen induced immune non-responsiveness

1994
- 1994-04-08 CA CA002159891A patent/CA2159891A1/en not_active Abandoned
- 1994-04-08 JP JP6523320A patent/JPH08508752A/ja active Pending
- 1994-04-08 AU AU65307/94A patent/AU6530794A/en not_active Abandoned
- 1994-04-08 EP EP94912969A patent/EP0692969A4/de not_active Withdrawn
- 1994-04-08 WO PCT/US1994/003861 patent/WO1994023734A1/en not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1991012818A1 (en) *	1990-02-23	1991-09-05	Immulogic Pharmaceutical Corporation	Superantigen induced immune non-responsiveness

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE FILE SERVER STN KARLSRUHE; IGNATOWICZ ET AL: "THE EFFECTS OF CHRONIC INFECTION WITH A SUPERANTIGEN-PRODUCING VIRUS", XP002032543 *
JOURNAL OF EXPERIMENTAL MEDICINE, vol. 175, no. 4, 1 April 1992 (1992-04-01), pages 917 - 923 *
MCCORMACK ET AL: "PROFOUND DELETION OF MATURE T CELLS IN VIVO BY CHRONIC EXPOSURE TO EXOGENOUS SUPERANTIGEN", THE JOURNAL OF IMMUNOLOGY, vol. 150, no. 9, 1 May 1993 (1993-05-01), pages 3785 - 3792, XP002032542 *
See also references of WO9423734A1 *
ZALLER ET AL: "PREVENTION AND TREATMENT OF MURINE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS WITH T CELL RECEPTOR VBETA-SPECIFIC ANTIBODIES", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 171, 1990, pages 1943 - 1955, XP000674640 *

Also Published As

Publication number	Publication date
CA2159891A1 (en)	1994-10-27
WO1994023734A1 (en)	1994-10-27
JPH08508752A (ja)	1996-09-17
EP0692969A1 (de)	1996-01-24
AU6530794A (en)	1994-11-08

Legal Events

Date	Code	Title	Description
1996-01-03	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1996-01-24	17P	Request for examination filed	Effective date: 19951107
1996-01-24	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-08-20	A4	Supplementary search report drawn up and despatched	Effective date: 19970704
1997-08-20	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-09-12	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
1997-10-08	18W	Application withdrawn	Withdrawal date: 19970818
1997-10-29	R18W	Application withdrawn (corrected)	Effective date: 19970814

Publication	Publication Date	Title
US5281607B1 (en)	1998-05-19	Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
IL106255A0 (en)	1993-11-15	Method for isolating human blood cells
GB9027968D0 (en)	1991-02-13	Method of treatment
AU4090289A (en)	1990-03-08	Method for the treatment of wool
AU7484791A (en)	1991-10-30	Method of treating diseases associated with elevated levels of interleukin 1
AU3730093A (en)	1993-09-13	Methods of treating diabetes
AU613355B2 (en)	1991-08-01	Method for treating skin diseases
EP0692969A4 (de)	1997-08-20	Methode zur behandlung von krankheiten durch deletion von t zellen
GB9218027D0 (en)	1992-10-14	Novel method of treatment
GB9202196D0 (en)	1992-03-18	Method of treatment
GB9226309D0 (en)	1993-02-10	Improved method of manufacture
AU8752991A (en)	1992-04-15	Method of treating auto-immune diseases using gallium compounds
GB9201391D0 (en)	1992-03-11	Method of treatment
AU665311C (en)	2001-02-15	Method of treatment of androgen-related diseases
GB9226371D0 (en)	1993-02-10	Novel method of treatment
GB9308853D0 (en)	1993-06-16	Novel method of treatment
GB9326020D0 (en)	1994-02-23	Novel method of treatment
GB9307004D0 (en)	1993-05-26	Method of treatment
GB9321796D0 (en)	1993-12-15	Method of treatment
GB9321971D0 (en)	1993-12-15	Method of treatment
GB9202698D0 (en)	1992-03-25	Method of treatment
GB9218188D0 (en)	1992-10-14	Method of treatment
GB9226252D0 (en)	1993-02-10	Method of treatment
GB9223252D0 (en)	1992-12-23	Method of treatment
GB9207275D0 (en)	1992-05-13	Method of treatment